インフォショップ ホームへ 株式会社グローバルインフォメーション
サイトマップ
その他のカテゴリ

商品カタログ

医療/バイオの調査資料販 MEDINFO.JP

バイオシミラー特集
バイオシミラー特集ページ バイオシミラーに関連したレポートを紹介致します。

Global Pharmaceuticals Research & Manufacturing 公式サイト

Translational Cancer Medicine 公式サイト

Outsourcing Asia Summit 2009 公式サイト

Global Healthcare Congress 2009 公式サイト

BioMedical Asia 2009 公式サイト

China 2009 Pharmaceutical R&D Summit 公式サイト

Drug Discovery & Development of Innovative Therapeutics Japan 2009 公式サイト

Drug Discovery & Development of Innovative Therapeutics 2009 公式サイト
English Korean Chinese
【 英文市場調査報告書 】

脳深部電気刺激療法(DBS)は神経科および精神科系薬剤市場にどのように影響を及ぼすか

How Will Deep Brain Stimulation Affect Neurological and Psychiatric Drug Markets?

商品コード : 44414 Decision Resources, Inc.
出版日 : 2006/08
発行 : Decision Resources, Inc.
電話でのお問い合わせ
価格情報
概要 原文目次
※この商品は英文にてご提供いたします。

Abstract

Introduction

Deep brain stimulation (DBS) is currently approved only to treat Parkinson's disease and Parkinson-like symptoms; however, clinical trials are under way for DBS in several other neurological and psychiatric disorders. As these surgical interventions gain acceptance in the face of conventional therapies' shortcomings in severely affected patients, opportunities are emerging for such devices, used both alone and in conjunction with existing drug regimens.

Get the Answers You Need to Shape Your Strategy

Currently, DBS is approved only for parkinsonism. For what other indications is DBS being investigated? What advantages does DBS offer to treat these indications? What potential exists for DBS in these indications? The risk factors associated with DBS have made it a last-resort therapy for most indications. How competitive will DBS be with conventional drug therapies? In which indications will it stand out? Will DBS ever be used as an early therapy, in any indication? Medtronic is the only company to have an approved device for DBS, although several companies have devices in development for other indications. Which of the companies developing DBS devices is best positioned to succeed in these new markets? What innovations must these companies provide to ensure success? Which company is poised to collaborate with drugmakers in creating a viable combination therapy?

Table of Contents

  • Executive Summary
  • Strategic Implications
  • Stakeholder Implications
  • Introduction
  • Overview of DBS
  • DBS for Specific Therapeutic Areas
  • Parkinson's Disease
  • Epilepsy
  • Psychiatric Disorders: OCD and Depression
  • Headaches
  • Companies Developing DBS Systems
  • Medtronic
  • NeuroPace
  • Cyberonics
  • Boston Scientific
  • Medtrode
  • Advanced Neuromodulation Systems
  • Impact of DBS on Drug Markets
  • Market Implications
  • DBS and the PD Market
  • DBS and the Epilepsy Market
  • DBS and the Psychiatric Markets
  • DBS and the Headache Market
  • Codevelopment of Pharmacological Agents and DBS
  • Outlook for DBS in the Marketplace
  • Bibliography

Tables

  • 1. Brain Regions Implicated in Epileptic Seizures
  • 2. Companies Developing DBS Devices

Figures

  • 1. Regions of the Brain Targeted for Deep Brain Stimulation
  • 2. Schematic of Deep Brain Stimulation
  • 3. Growth of DBS Procedures, by Indication, 2005-2015
概要 原文目次
※この商品は英文にてご提供いたします。
【 英文市場調査報告書 】
脳深部電気刺激療法(DBS)は神経科および精神科系薬剤市場にどのように影響を及ぼすか
How Will Deep Brain Stimulation Affect Neurological and Psychiatric Drug Markets?
出版日 : 2006/08
電話でのお問い合わせ
この商品について問い合わせる
この商品のサンプル(抜粋)を依頼する
価格

※ドル建て価格の商品のお支払いは、為替レート (TTS: 94.69) 換算による円建てのご請求書にて承ります。

US $ 1,112 換算 -> ¥ 105,295 (税抜) PDF by E-mail (Single User License)
商品コード : 44414